Search - tctmd.com

Displaying 141 - 160 of 272

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Daily News

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Michael O'Riordan

February 27, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Prior PCI Does Not Affect Early CABG Outcomes: Registry and Meta-analysis

Leah Lawrence

February 16, 2018

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

News Daily News

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Yael L. Maxwell

February 06, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Multiarterial CABG Gets a Boost in Retrospective Analysis

Yael L. Maxwell

October 12, 2017

News Daily News

Women Receive Less Aggressive CABG Compared With Men

Yael L. Maxwell

September 29, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

News Industry News

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

February 07, 2017

News Daily News

Multiarterial Approach to CABG Still Entails Higher Risk but Might Unlock the Door to Better Long-term Survival

Yael L. Maxwell

January 25, 2017

News Daily News

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Caitlin E. Cox

December 21, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for February 2018

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Prior PCI Does Not Affect Early CABG Outcomes: Registry and Meta-analysis

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Multiarterial CABG Gets a Boost in Retrospective Analysis

Women Receive Less Aggressive CABG Compared With Men

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

Multiarterial Approach to CABG Still Entails Higher Risk but Might Unlock the Door to Better Long-term Survival

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content